Total Payments
$15,740
2024 Payments
$1,529
Companies
45
Transactions
628
Medicare Patients
47,554
Medicare Billing
$6.1M
Payment Breakdown by Category
Food & Beverage$14,534 (92.3%)
Research$1,170 (7.4%)
Education$36.17 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,534 | 616 | 92.3% |
| Unspecified | $1,170 | 7 | 7.4% |
| Education | $36.17 | 5 | 0.2% |
Payments by Type
General
$14,570
621 transactions
Research
$1,170
7 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $4,028 | 199 | $0 (2024) |
| Boston Scientific Corporation | $1,990 | 22 | $0 (2023) |
| Abbott Laboratories | $1,618 | 16 | $0 (2024) |
| Medtronic, Inc. | $669.22 | 8 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $628.78 | 42 | $0 (2024) |
| Medtronic Vascular, Inc. | $593.61 | 7 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $592.07 | 25 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $579.43 | 30 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $526.93 | 35 | $0 (2024) |
| BIOTRONIK INC. | $521.10 | 6 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,529 | 69 | Amgen Inc. ($554.80) |
| 2023 | $2,188 | 90 | Amgen Inc. ($725.57) |
| 2022 | $1,727 | 67 | Amgen Inc. ($627.64) |
| 2021 | $771.28 | 32 | Amgen Inc. ($278.81) |
| 2020 | $1,049 | 40 | Amgen Inc. ($354.45) |
| 2019 | $2,639 | 73 | Amgen Inc. ($582.81) |
| 2018 | $2,542 | 110 | Amgen Inc. ($458.06) |
| 2017 | $3,295 | 147 | BOSTON SCIENTIFIC CORPORATION ($622.55) |
All Payment Transactions
628 individual payment records from CMS Open Payments — Page 1 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $9.16 | General |
| Category: Cardiology | ||||||
| 12/16/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/12/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $19.32 | General |
| Category: Cardiology | ||||||
| 12/10/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $11.08 | General |
| Category: Cardiology | ||||||
| 12/06/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $0.24 | General |
| Category: Cardiology | ||||||
| 12/05/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/26/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $24.88 | General |
| Category: Cardiovascular | ||||||
| 11/21/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $18.79 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/19/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $10.72 | General |
| Category: Cardiology | ||||||
| 11/15/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $12.01 | General |
| Category: Cardiology | ||||||
| 11/12/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $22.39 | General |
| Category: Cardiology | ||||||
| 11/07/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $10.25 | General |
| Category: Cardiology | ||||||
| 11/04/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $11.74 | General |
| Category: Cardiology | ||||||
| 10/23/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $25.28 | General |
| Category: Cardiovascular | ||||||
| 10/07/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $27.35 | General |
| Category: Cardiology | ||||||
| 10/04/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $19.94 | General |
| Category: Cardiology | ||||||
| 10/04/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $2.31 | General |
| Category: Cardiology | ||||||
| 10/02/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $15.25 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/01/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: Not Applicable | ||||||
| 09/30/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/26/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $23.83 | General |
| Category: Cardiovascular | ||||||
| 09/24/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: Cardiology | ||||||
| 09/11/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $1.86 | General |
| Category: Cardiology | ||||||
| 09/10/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: Cardiology | ||||||
| 08/29/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $17.66 | General |
| Category: Cardiology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| St. Jude Medical Product Longevity and Performance (SCORE) Registry | Abbott Laboratories | $720.00 | 4 |
| SCORE | Abbott Laboratories | $280.00 | 1 |
| OPTIMUM Lead Registry | Abbott Laboratories | $150.00 | 1 |
| Optim Lead Insulation Material (OPTIMUM) Registry | Abbott Laboratories | $20.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 30 | 10,651 | 14,102 | $3.4M | $1.3M |
| 2022 | 31 | 11,834 | 15,919 | $3.7M | $1.5M |
| 2021 | 32 | 12,335 | 16,596 | $3.9M | $1.6M |
| 2020 | 28 | 12,734 | 17,185 | $4.2M | $1.7M |
Total Patients
47,554
Total Services
63,802
Medicare Billing
$6.1M
Procedure Codes
121
All Medicare Procedures & Services
121 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2023 | 385 | 394 | $472,800 | $279,884 | 59.2% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 677 | 677 | $677,000 | $248,423 | 36.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 1,596 | 2,118 | $296,520 | $193,618 | 65.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 994 | 1,012 | $708,400 | $147,952 | 20.9% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 590 | 2,360 | $236,000 | $102,835 | 43.6% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 656 | 657 | $216,810 | $95,675 | 44.1% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 663 | 1,324 | $64,004 | $49,632 | 77.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 613 | 644 | $64,400 | $43,576 | 67.7% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 691 | 693 | $173,250 | $40,173 | 23.2% |
| 93224 | Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | Office | 2023 | 397 | 407 | $122,100 | $22,610 | 18.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 299 | 299 | $53,820 | $20,395 | 37.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 1,793 | 1,910 | $114,600 | $19,951 | 17.4% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2023 | 106 | 106 | $47,700 | $19,752 | 41.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 116 | 116 | $26,680 | $13,703 | 51.4% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 150 | 243 | $24,300 | $13,378 | 55.1% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 384 | 393 | $19,650 | $7,501 | 38.2% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 32 | 80 | $7,600 | $5,514 | 72.6% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Office | 2023 | 106 | 106 | $20,140 | $4,501 | 22.3% |
| 93284 | Programming of multiple lead implantable defibrillator system | Office | 2023 | 23 | 54 | $8,100 | $4,143 | 51.2% |
| 93283 | Programming of dual lead implantable defibrillator system | Office | 2023 | 21 | 37 | $4,810 | $2,175 | 45.2% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Office | 2023 | 106 | 106 | $19,080 | $2,117 | 11.1% |
| 93279 | Programming of single lead pacemaker system | Office | 2023 | 22 | 37 | $3,145 | $1,786 | 56.8% |
| 93297 | Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | Office | 2023 | 24 | 74 | $3,700 | $1,473 | 39.8% |
| 93290 | Evaluation of implantable heart and blood vessel monitoring system | Office | 2023 | 20 | 27 | $1,350 | $934.32 | 69.2% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 41 | 49 | $2,940 | $839.52 | 28.6% |
About Dr. Sam Borno, MD
Dr. Sam Borno, MD is a Interventional Cardiology healthcare provider based in Fresno, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/25/2005. The National Provider Identifier (NPI) number assigned to this provider is 1598758468.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sam Borno, MD has received a total of $15,740 in payments from pharmaceutical and medical device companies, with $1,529 received in 2024. These payments were reported across 628 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($14,534).
As a Medicare-enrolled provider, Borno has provided services to 47,554 Medicare beneficiaries, totaling 63,802 services with total Medicare billing of $6.1M. Data is available for 4 years (2020–2023), covering 121 distinct procedure/service records.
Ad
Practice Information
- Specialty Interventional Cardiology
- Location Fresno, CA
- Active Since 08/25/2005
- Last Updated 09/27/2012
- Taxonomy Code 207RI0011X
- Entity Type Individual
- NPI Number 1598758468
Products in Payments
- Repatha (Biological) $3,217
- Corlanor (Drug) $793.75
- Cardiovascular-Research Only (Device) $720.00
- XARELTO (Drug) $628.78
- ELIQUIS (Drug) $597.79
- ENTRESTO (Drug) $534.99
- LifeVest (Device) $526.93
- CRM-Research only (Device) $430.00
- Reveal LINQ (Device) $349.51
- LATITUDE (Device) $321.13
- PRADAXA (Drug) $302.28
- JARDIANCE (Drug) $277.15
- VERQUVO (Drug) $260.74
- Barostim Neo System (Device) $252.21
- ZONTIVITY (Drug) $251.75
- AZURE XT DR MRI SURESCAN (Device) $232.71
- BRILINTA (Drug) $232.00
- Advisa (Device) $231.67
- DYNAGEN (Device) $219.76
- TEGSEDI (Drug) $210.30
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Interventional Cardiology Doctors in Fresno
Dr. Bhavik Khatri, D.o, D.O
Interventional Cardiology — Payments: $22,208
Interventional Cardiology $22,208
Dr. Charles Sohn, Md, MD
Interventional Cardiology — Payments: $18,043
Interventional Cardiology $18,043
Donald Gregory, M.d.,Facc, M.D.,FACC
Interventional Cardiology — Payments: $6,327
Interventional Cardiology $6,327
Bala Iyer, Md, MD
Interventional Cardiology — Payments: $4,862
Interventional Cardiology $4,862
Amir Sanati, Md, MD
Interventional Cardiology — Payments: $4,661
Interventional Cardiology $4,661
Harcharn Chann, Md, MD
Interventional Cardiology
Interventional Cardiology